Arbutus Biopharma Corp (NASDAQ:ABUS)

3.18
Delayed Data
As of Apr 18
 -0.19 / -5.64%
Today’s Change
3.18
Today|||52-Week Range
12.60
-16.97%
Year-to-Date
4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics
Apr 11 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for April 8th
Apr 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.37
Today’s open3.33
Day’s range3.18 - 3.42
Volume725,754
Average volume (3 months)202,827
Market cap$209.9M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+22.17%
Earnings growth (this year)-7.58%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-44.44%
P/E ratioNM
Price/Sales35.63
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...0.000.00%
PRTKParatek Pharmaceutic...0.000.00%
CHMAChiasma Inc+0.10+1.71%
FOMXFoamix Pharmaceutica...-0.05-1.46%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.9M
Annual profit (last year)-$57.1M
Net profit margin-959.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial &
Accounting Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts